# Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparing-pioglitazone-to-insulin-with-respect-to-cancer-cardiovascular-and-bone/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carlos Vallarino,Alfonso García‐Pérez,Gregory Fusco,Huifang Liang,Morgan Bron,Sudhakar Manne,Guiandre Joseph,Shawn Yu |
| Citations | 53 |
| DOI | 10.1007/s40261-013-0106-9 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40261-013-0106-9.pdf |
| OpenAlex ID | https://openalex.org/W1972990210 |
| PMID | 23881565 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Morgan Bron](https://scholariq.org/researchers/morgan-bron/)

## Paper journal

- [Clinical Drug Investigation](https://scholariq.org/journals/clinical-drug-investigation/)

## Paper primary topic

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Paper topics

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.